Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > asking for a friend

<< Previous

Bullboard Posts

Next >>

Post by juicyjmillson Dec 16, 2020 10:01am

141 Views

Post# 32117789

asking for a friend

did i change anyones life by recommending buying digital assets the beginning of this year? did anyone regret not listening to me? 2021 will be no different, 2030, and 2035... if you listened to me you wouldnt be waitinf for your 10x on ATE anymore, you would have left 10x behind months ago and be waiting for 100x, 1000x, 10000x in the digital asset space. the last (most stubborn, old school, conservative, ignorant) investors to switch over will regret it the most.

like i've said before... if you still dont own digital assets then you don't understand the markets anymore. DYOR and dont be the guy buying my digital assets from me in 2025 for 1000x the price lol

<< Previous

Bullboard Posts

Next >>

The investment impact of the U.S. 25% tariff on Canadian imports